1. Neurological complications of beta-thalassemia

   • P. Nemtsas
   • M. Arnaoutoglou
   • A. Orologas

   Review Article 24 April 2015 Pages: 1261 - 1265

2. Repurposing medicinal compounds for blood cancer treatment

   • Bronagh McCabe
   • Fabio Liberante
   • Ken I. Mills

   Review Article Open access 07 June 2015 Pages: 1267 - 1276

   

3. Mean corpuscular volume of control red blood cells determines the interpretation of eosin-5′-maleimide (EMA) test result in infants aged less than 6 months

   • Olga Ciepiela
   • Anna Adamowicz-Salach
   • Iwona Kotuła

   Original Article Open access 25 April 2015 Pages: 1277 - 1283

   

4. Microparticle source and tissue factor expression in pregnancy

   • Amy E. Wong
   • Hau C. Kwaan
   • Cynthia A. Wong

   Original Article 01 April 2015 Pages: 1285 - 1290

5. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome

   • Mecki Isert
   • Wolfgang Miesbach
   • Birgit Linnemann

   Original Article 10 April 2015 Pages: 1291 - 1299

   

6. Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause

   • J. Gebhart
   • C. Laczkovics
   • I. Pabinger

   Original Article 15 May 2015 Pages: 1301 - 1310

   

7. Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only

   • M. M. Chao
   • J. S. Kuehl
   • W. Ebell

   Original Article 12 April 2015 Pages: 1311 - 1318

   

8. Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients

   • F. Buccisano
   • L. Maurillo
   • A. Venditti

   Original Article 14 April 2015 Pages: 1319 - 1326

   

9. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

   • Jana Schweitzer
   • Martin Zimmermann
   • Jan-Henning Klusmann

   Original Article Open access 28 April 2015 Pages: 1327 - 1336

   

10. Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia

    • Tanja Schneider
    • Anne Flörcken
    • Jörg Westermann

    Original Article 22 May 2015 Pages: 1337 - 1345

    

11. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

    • Miguel A. Sanz
    • Pau Montesinos
    • on behalf of the IC-APL and PETHEMA and HOVON Groups

    Original Article 15 May 2015 Pages: 1347 - 1356

    

12. Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia

    • Miguel A. Sanz
    • Pau Montesinos
    • Alfredo Perales

    Original Article 25 April 2015 Pages: 1357 - 1361

13. Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?

    • David Gurrea Salas
    • Ingmar Glauche
    • Meinolf Suttorp

    Original Article 19 April 2015 Pages: 1363 - 1371

    

14. Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

    • M. W. M. van der Poel
    • W. J. Mulder
    • H. C. Schouten

    Original Article Open access 14 April 2015 Pages: 1373 - 1379

    

15. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type

    • Liang Wang
    • Hua Wang
    • Yu-jing Zhang

    Original Article 14 April 2015 Pages: 1381 - 1388

    

16. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type

    • Kai-Lin Chen
    • Yan-Hui Liu
    • Qing-Qing Cai

    Original Article 15 April 2015 Pages: 1389 - 1400

    

17. Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children

    • Marie Jaffray
    • Nimrod Buchbinder
    • Jean-Pierre Vannier

    Original Article 12 April 2015 Pages: 1401 - 1406

18. Agreement of point-of-care INR test with standard venous sampling assay at higher extreme ranges

    • Y. F. Lai
    • M. C. Kong
    • H. J. Ng

    Letter to the Editor 11 April 2015 Pages: 1407 - 1408

    

19. Sense, missense, and nonsense: a novel mechanism of premature termination codon (PTC) mutation in a severe von Willebrand disease (VWD) patient

    • Priyanka Kasatkar
    • Bipin Kulkarni
    • Shrimati Shetty

    Letter to the Editor 15 April 2015 Pages: 1409 - 1410

20. Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III

    • Gonzalo Carreno-Tarragona
    • Francisco Trapiello-Valbuena
    • Carmen Díaz-Pedroche

    Letter to the Editor 22 April 2015 Pages: 1411 - 1412

    

21. Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage?

    • Alexa J. Siddon
    • Henry M. Rinder
    • Christopher A. Tormey

    Letter to the Editor 02 June 2015 Pages: 1413 - 1414

    

22. Fulminant pneumococcal bacteraemia revealed by automated digital cell morphology analysis (CellaVision DM96)

    • Maite Serrando i Querol
    • Cristian Morales-Indiano
    • Esperanza Tuset Andujar

    Letter to the Editor 14 April 2015 Pages: 1415 - 1416

    

23. Leishmaniasis involving the bone marrow of a patient with multiple myeloma

    • M. Alahmadi
    • I. H. Chin-Yee
    • C. C. Hsia

    Letter to the Editor 17 April 2015 Pages: 1417 - 1418

    

24. Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia

    • Song-Yau Wang
    • Thomas Ebert
    • Haifa Kathrin Al-Ali

    Letter to the Editor 24 April 2015 Pages: 1419 - 1420

25. Isochromosome 17q10 associated with basophilia in primary myelofibrosis while with JAK2 inhibitor

    • S. Koumas
    • C. Prokopiou
    • N. Neokleous

    Letter to the Editor 22 April 2015 Pages: 1421 - 1422

26. Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement

    • Mario Tiribelli
    • Daniela Barraco
    • Renato Fanin

    Letter to the Editor 23 April 2015 Pages: 1423 - 1424

27. Fatal pulmonary hemorrhage after carfilzomib treatment in multiple myeloma

    • Yok-Lam Kwong

    Letter to the Editor 06 May 2015 Pages: 1425 - 1426

    

28. Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm

    • Chhagan Bihari
    • Archana Rastogi
    • Anupam Kumar

    Letter to the Editor 14 May 2015 Pages: 1427 - 1429

    

29. Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia

    • Shinichi Ogawa
    • Yasuhisa Yokoyama
    • Shigeru Chiba

    Letter to the Editor 03 May 2015 Pages: 1431 - 1433

    

30. Eosinophilic gastroenteritis after allogeneic bone marrow transplantation

    • Hiroto Ishii
    • Takaaki Konuma
    • Satoshi Takahashi

    Letter to the Editor 28 April 2015 Pages: 1435 - 1436

    

31. Angioimmunoblastic T-cell lymphomas presenting as autoimmune hemolytic anemias: clinical manifestations and circulating cytokine features

    • Boting Wu
    • Weiguang Wang
    • Yunfeng Cheng

    Letter to the Editor 30 April 2015 Pages: 1437 - 1439